Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer
Issued Date
2025-02-01
Resource Type
ISSN
01695002
eISSN
18728332
Scopus ID
2-s2.0-85214326522
Journal Title
Lung Cancer
Volume
200
Rights Holder(s)
SCOPUS
Bibliographic Citation
Lung Cancer Vol.200 (2025)
Suggested Citation
Saw S.P.L., Zhong W.Z., Fu R., Li M.S.C., Goto Y., Fox S.B., Yatabe Y., Ong B.H., Ng C.S.H., Lee D.D.W., Cam Phuong P., Park I.K., Yang J.C.H., Tsuboi M., Tho L.M., John T., Hsu H.H., Tan D.S.W., Mok T.S.K., Reungwetwattana T., Singh N. Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer. Lung Cancer Vol.200 (2025). doi:10.1016/j.lungcan.2024.108076 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/102973
Title
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer
Author's Affiliation
National Taiwan University Hospital
Bach Mai Hospital
Guangdong Provincial People’s Hospital of Southern Medical University
National Cancer Centre, Singapore
Universiti Malaya
University of Melbourne
National Cancer Center Japan
National Cancer Center Hospital
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Seoul National University
National Cancer Center Hospital East
National Heart Centre Singapore
Chinese University of Hong Kong
Postgraduate Institute of Medical Education and Research, Chandigarh
Beacon Hospital
Bach Mai Hospital
Guangdong Provincial People’s Hospital of Southern Medical University
National Cancer Centre, Singapore
Universiti Malaya
University of Melbourne
National Cancer Center Japan
National Cancer Center Hospital
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Seoul National University
National Cancer Center Hospital East
National Heart Centre Singapore
Chinese University of Hong Kong
Postgraduate Institute of Medical Education and Research, Chandigarh
Beacon Hospital
Corresponding Author(s)
Other Contributor(s)
Abstract
The peri-operative management of non-small cell lung cancer (NSCLC) in earlier stage disease has seen significant advances in recent years with the incorporation of immune checkpoint inhibitors and targeted therapy. However, many unanswered questions and challenges remain, including the application of clinical trial data to routine clinical practice. Recognising the unique demographic profile of Asian patients with NSCLC and heterogeneous healthcare systems, the Asian Thoracic Oncology Research Group (ATORG) convened a consensus meeting in Singapore on 26 April 2024 to discuss relevant issues spanning diagnostic testing to post-neoadjuvant treatment considerations and future directions. An interdisciplinary group of 19 experts comprising medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists and pathologists from Singapore, Hong Kong, Mainland China, Korea, Japan, Taiwan, India, Malaysia, Thailand, Vietnam and Australia met to discuss emerging data, identify existing gaps in clinical care and develop a multidisciplinary, multinational expert consensus statement on the peri-operative management of NSCLC tailored to the Asia-Pacific region.